Vascular Treatment Articles & Analysis
28 news found
Transcranial techniques are improving neurological diagnostics, while tumor tissue-based technology is revolutionizing cancer treatment, particularly in prostate cancer screening. In dermatology, new methods for treating benign epidermal lesions are emerging, alongside the development of drug-free therapies to enhance patient well-being. ...
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the AlphaVac F1885 System for the non-surgical removal of thrombi or emboli from the pulmonary ...
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). ...
It occupies a very important position in the field of skin beauty and is widely used in the treatment of various skin damages, especially those related to photodamage and photoaging. ...
In fact, in spite of the very low temperature reached, -10°C, and kept constant during the 50 minutes of treatment, the vascularization and the tonicity of the tissues of the treated area are preserved, as well as the cellular structures and their functionality. ...
IPL photorejuvenation treatment is currently the most advanced high-tech beauty program, and it is also the safest and most effective beauty program. ...
(“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, is pleased to announce the closing of a $45 million Series B equity financing. ...
End of study brings Robocath closer to commercializing R-One in China in 2023 149 patients enrolled over six months in four Chinese centers Results of first vascular robotics study on this scale in China will be published in March 2023 Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of ...
ByRobocath
Kabnick holds patents for the development of devices used during endovenous thermal treatment. He was the first vascular surgeon in the U.S. to perform two breakthrough procedures for treating venous disease. ...
(“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, is pleased to announce the presentation of the 6- month clinical outcomes data from a post market study of the Company’s MOTIV Below The Knee (BTK) scaffold. ...
(“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications is pleased to announce exceptional 5 Year clinical results from its FANTOM II Study. ...
100% clinical success rate: zero complications linked to robot up to 30 days post-procedure >95% technical success rate 84.5% average reduction in physician radiation exposure Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today presents the results of its R-Evolution ...
ByRobocath
The innovation achieved so far is truly outstanding and has significant potential to aid clinicians in the treatment of coronary and vascular disease and ultimately bring a better quality of life to patients all over the ...
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today that it has concluded its ‘R-Evolution’ clinical study. ...
ByRobocath
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform. ...
ByRobocath
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today its successful first robotic carotid stenting at Rennes University Hospital. ...
ByRobocath
This prospective, multi-center clinical trial is the first study designed to evaluate the clinical benefits of direct aspiration for the treatment of ischemic stroke with the Zoom 88 Large Distal Platform, which is currently FDA cleared for neurovascular access. ...
It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases. The company employs a total of 400 people, including 300 in Geneva and 40 in Fribourg. ...
“Imperative Care’s intentional mission to impact the continuum of stroke care and vascular thrombectomy, elevating innovations in order to make more care available to more patients globally, requires a Board with a long-term horizon and broad expertise. ...
The proceeds from the Series D financing will also be used to advance Truvic’s development and commercialization of novel technologies for the treatment of peripheral vascular disease. “We are grateful for the confidence our investors have placed in us through this major financing, which we believe will have a profound impact on our ability to ...